Posted inUncategorized
Medical Biopharmaceutical Deal Gives Sentynl U.S. and Global Manufacturing Rights to Mereo’s Alvelestat
Sentynl Therapeutics has entered into an option and license agreement with Mereo BioPharma Group to secure potential U.S. commercial rights and global manufacturing rights for alvelestat, an investigational therapy being…